Regional People with overweight, all classes of obesity, and T2D spotlighting the frequent concurrence of the two conditions Obesity x T2D overlap Wegovy and Zepbound are not FDA-approved to treat type 2 diabetes, but in clinical trials, in addition to losing weight, patients saw improvements in blood glucose levels
healthcare system is at a turning point as the dual epidemics of obesity and type 2 diabetes drive demand for advanced treatments
Tirzepatide vs Semaglutide Once Weekly for Weight Loss (SURMOUNT-5)
Pulmonary Fibrosis Fibrosis of the lung disrupts alveolar architecture and impairs gas exchange, representing a central pathological feature of fibrotic interstitial lung diseases
Prioritizing 7 to 9 hours of quality sleep supports better outcomes
In TRIUMPH-4, nausea reached up to 43% at the 12mg dose, and retatrutide introduced a dysesthesia (altered skin sensation) signal not seen with semaglutide or tirzepatide